New drug approval: Lenvatinib plus pembrolizumab for advanced renal cell carcinoma

被引：0
|
作者：
Saillant, Arnaud [1 ]
Borchiellini, Delphine [2 ]
机构：
[1] Ctr Hosp Univ Poitiers, Dept Oncol Med, F-86021 Poitiers, France
[2] Univ Cote dAzur, Dept Oncol Med, Ctr Antoine Lacassagne, Nice, France
来源：
BULLETIN DU CANCER | 2022年 / 109卷 / 7-8期
关键词：
Carcinoma renal cell; Antineoplastic Agents; Antibodies Monoclonal; Immunotherapy;
D O I：
10.1016/j.bulcan.2022.03.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：737 / +
页数：2
相关论文
共 50 条
  • [31] Genomic biomarkers of response to lenvatinib/pembrolizumab (Len/Pembro) in patients with advanced renal cell carcinoma
    Lee, Chung-Han
    DiNatale, Renzo G.
    Chowell, Diego
    Krishna, Chriag
    Makarov, Vladimir
    Shapnik, Natalie
    Murray, Samuel J.
    Carlo, Maria Isabel
    Voss, Martin H.
    Feldman, Darren R.
    Hakimi, A. Ari
    Adachi, Yusuke
    Minoshima, Yukinori
    Matsui, Junji
    Funahashi, Yasuhiro
    Perini, Rodolfo F.
    Nomoto, Kenichi
    Motzer, Robert J.
    Chan, Timothy An-thy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [32] The implementation of lenvatinib/everolimus or lenvatinib/pembrolizumab combinations in the treatment of metastatic renal cell carcinoma
    Jacob, Allen
    Shook, Jaret
    Hutson, Thomas
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (04) : 365 - 372
  • [33] Characterization and management of adverse reactions (ARs) in patients with advanced renal cell carcinoma (aRCC) receiving lenvatinib plus pembrolizumab (CLEAR study)
    Motzer, Robert
    George, Saby
    Merchan, Jaime R.
    Hutson, Thomas E.
    Song, Xun
    Perini, Rodolfo F.
    Xie, Ran
    Bapat, Urmi
    Ebaid, Basant
    Puente, Javier
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 121 - 122
  • [34] Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
    Grunwald, Viktor
    Powles, Thomas
    Eto, Masatoshi
    Kopyltsov, Evgeny
    Rha, Sun Young
    Porta, Camillo
    Motzer, Robert
    Hutson, Thomas E.
    Mendez-Vidal, Maria Jose
    Hong, Sung-Hoo
    Winquist, Eric
    Goh, Jeffrey C.
    Maroto, Pablo
    Buchler, Tomas
    Takagi, Toshio
    Burgents, Joseph E.
    Perini, Rodolfo
    He, Cixin
    Okpara, Chinyere E.
    McKenzie, Jodi
    Choueiri, Toni K.
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [35] Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
    Gruenwald, V.
    Powles, T.
    Eto, M.
    Kopyltsov, E.
    Rha, S. Y.
    Porta, C.
    Motzer, R.
    Hutson, T. E.
    Mendez-Vidal, M. J.
    Hong, S. H.
    Winquist, E.
    Goh, J. C.
    Maroto, P.
    Buchler, T.
    Takagi, T.
    Burgents, J. E.
    Perini, R.
    He, C.
    Okpara, C. E.
    McKenzie, J.
    Choueiri, T. K.
    [J]. ONKOUROLOGIYA, 2024, 20 (01): : 24 - 35
  • [36] A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with renal cell carcinoma
    Lee, C-H.
    Makker, V.
    Rasco, D.
    Taylor, M.
    Dutcus, C.
    Shumaker, R.
    Schmidt, E. V.
    Stepan, D.
    Li, D.
    Motzer, R. J.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [37] Management of Adverse Reactions Related to Lenvatinib Plus Pembrolizumab Treatment Among Patients With Renal Cell Carcinoma
    Gruenwald, Viktor
    Larkin, James
    Puente, Javier
    Bedke, Jens
    Porta, Camillo
    [J]. CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 394 - 401
  • [38] Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors
    Taylor, Matthew H.
    Lee, Chung-Han
    Makker, Vicky
    Rasco, Drew
    Dutcus, Corina E.
    Wu, Jane
    Stepan, Daniel E.
    Shumaker, Robert C.
    Motzer, Robert J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (11) : 1154 - +
  • [39] Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
    Rini, Brian I.
    Plimack, Elizabeth R.
    Stus, Viktor
    Gafanov, Rustem
    Hawkins, Robert
    Nosov, Dmitry
    Pouliot, Frederic
    Alekseev, Boris
    Soulieres, Denis
    Melichar, Bohuslav
    Vynnychenko, Ihor
    Kryzhanivska, Anna
    Bondarenko, Igor
    Azevedo, Sergio J.
    Borchiellini, Delphine
    Szczylik, Cezary
    Markus, Maurice
    McDermott, Raymond S.
    Bedke, Jens
    Tartas, Sophie
    Chang, Yen-Hwa
    Tamada, Satoshi
    Shou, Qiong
    Perini, Rodolfo F.
    Chen, Mei
    Atkins, Michael B.
    Powles, Thomas
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (12): : 1116 - 1127
  • [40] Initial clinical experience of pembrolizumab plus axitinib for advanced renal cell carcinoma
    Ieda, Takeshi
    Anno, Yuta
    Kurosawa, Makoto
    Kure, Akimasa
    Koyasu, Hiroki
    Takahata, Sohei
    Hino, Amiko
    Kitamura, Kosuke
    Nagata, Masayoshi
    Wakumoto, Yoshiaki
    Sakamoto, Yoshiro
    Tsujimura, Akira
    Horie, Shigeo
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 : 6 - 7
12345